ESHAP is an active regimen for relapsing Hodgkin's disease.
Aparicio, J
ESHAP is an active regimen for relapsing Hodgkin's disease. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 1999 - 593-5 p. digital
Publication Type: Clinical Trial; Journal Article
0923-7534
10.1023/a:1026454831340 doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Cytarabine--administration & dosage
Etoposide--administration & dosage
Female
Hodgkin Disease--drug therapy
Humans
Male
Methylprednisolone--administration & dosage
Middle Aged
Prospective Studies
ESHAP is an active regimen for relapsing Hodgkin's disease. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 1999 - 593-5 p. digital
Publication Type: Clinical Trial; Journal Article
0923-7534
10.1023/a:1026454831340 doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Cytarabine--administration & dosage
Etoposide--administration & dosage
Female
Hodgkin Disease--drug therapy
Humans
Male
Methylprednisolone--administration & dosage
Middle Aged
Prospective Studies